Melanoma Clinical Trials in Rotterdam
2 recruitingRotterdam, Netherlands
Showing 1–2 of 2 trials
Recruiting
Phase 1Phase 2
Intradermal Ipilimumab and Nivolumab in High Risk Stage II Melanoma
Melanoma
The Netherlands Cancer Institute96 enrolled6 locationsNCT06240143
Recruiting
Phase 1Phase 2
Evaluating the Effect of Nivolumab for Patients With In-transit Metastases Treated With Isolated Limb Perfusion
MelanomaIn-Transit Metastasis
Vastra Gotaland Region74 enrolled4 locationsNCT03685890